Roman Viktorovich Ishchenko

Roman Viktorovich Ishchenko

Auto-generated profile, based on publicly available information

Roman Viktorovich Ishchenko

V. K. Gusak institute of emergency and reconstructive surgery; Lomonosov Moscow State Universit

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 July 2022 in Journal of Clinical Practice
Verified
Journal Article
Open access
PDF file
OSOksana Yu. Stukalova
Oksana Yu. Stukalova
APAleksey Aleksandrovich Polikarpov
Aleksey Aleksandrovich Polikarpov
RIRoman V. Ishchenko
Roman V. Ishchenko
ZSZaurbek Kh. Shugushev
Zaurbek Kh. Shugushev
Background: At present, the problem of treating common forms of colorectal cancer does not lose its relevance due to the increase in its incidence. Systemic chemotherapy is the main line of treatment for patients with unresectable liver metastases. However, a significant problem of modern oncology is the further treatment tactics for patients with chemoresistant metastases. Aims: to improve the treatment results for patients with chemoresistant liver metastases of colorectal cancer. Method: 36 patients with unresectable liver metastases of colorectal cancer were treated at the Granov Russian Research Center of Radiology and Surgical Technologies and the RZD-Medicine Central Clinical Hospital. For all the patients, systemic chemotherapy was considered unreasonable due to the development of chemoresistance or a high degree of toxicity. The patients underwent regional chemotherapy chemoinfusion and/or chemoembolization of the hepatic artery. Results: The treatment evaluation was performed using the RECIST 1.1 scale. After 6 months, a partial response was reached in 1 patient (2.8%), stabilization was observed in 29 (80.5%) patients, and 6 patients (16.7%) had the disease progression. In 2 (5.6%) cases, a lethal outcome was observed against the background of the systemic progression of the oncological disease. One year later, stabilization of the malignant process was detected in 21 (58.3%) cases, progression was detected in 15 (41.7%) cases. A one-year survival of patients was 83.3%, the overall survival 22 months. Conclusion: The use of interventional radiology methods has shown its effectiveness in patients with unresectable chemoresistant liver metastases of colorectal cancer.

15 November 2024 in South Russian Journal of Cancer
Verified
Journal Article
Open access
PDF file
EKE. O. Kalmykova
E. O. Kalmykova
RIR. V. Ishchenko
R. V. Ishchenko
OSO. Yu. Stukalova
O. Yu. Stukalova
Dmitry FilimonovDmitry Filimonov
Dmitry Filimonov
Purpose of the study. To improve the treatment results of patients suffering from CRC with oligometastatic lesion by determining the most effective combination of treatment methods.Patients and methods. The results of treatment of 71 patients with oligometastases of colorectal cancer were analyzed. All patients were divided into 2 groups depending on the treatment methods. The first group included 35 patients who underwent simultaneous removal of the primary tumor and metastatic foci at the first stage of complex treatment. The second group includes clinical data on 36 patients who underwent primary lesion removal at the first stage of complex treatment followed by drug antitumor therapy.Results. In the primary tumor removal group, the response was received in 3 (8.3 %) cases, stabilization was achieved in 14 (38.9 %) cases, and progression of the tumor process was detected in 19 (52.8 %) cases. The median disease-free survival was 9.2 ± 3.2 months. One-year, two- and three-year survival rates in the group of simultaneous removal of the primary tumor and oligometastases and in the group of primary tumor removal were 97.1 %, 88.6 %, 77.1 % and 100 %, 80.5 %, 72.2 %, respectively. The overall survival rate in the group of simultaneous removal of the primary tumor and oligometastases was 63 ± 3.9 months, in the group of primary tumor removal – 58 ± 3.8 months.Conclusion. In the presented clinical study, a comparative assessment of the effectiveness of the treatment of patients with colorectal cancer with oligometastases was carried out, depending on the option of an integrated approach. The results obtained turned out to be multidirectional – the response to treatment and progression were obtained in 54.3 % and 45.7 % of cases in the group of simultaneous removal of the primary tumor and oligometastases versus 47.2 % and 52.8 % of cases in the group of removal of the primary tumor without oligometastases, respectively. The median recurrence-free survival was shorter in the group of primary tumor removal without metastases. Complete removal of the primary tumor and oligometastases can significantly increase the overall survival rates of patients.

18 November 2024 in South Russian Journal of Cancer
Verified
Journal Article
Open access
PDF file
OSO. Yu. Stukalova
O. Yu. Stukalova
RIR. V. Ishchenko
R. V. Ishchenko
APA. A. Polikarpov
A. A. Polikarpov
AFA. I. Farmonkulova
A. I. Farmonkulova
Purpose of the study. To improve the results of treatment of patients with unresectable metastases of colorectal cancer in the liver that are not controlled by systemic chemotherapy.Materials and methods. The study includes clinical data on the treatment of 76 patients with metachronous metastases of colorectal cancer in the liver that are not controlled by systemic chemotherapy. Patients underwent removal of the primary tumor according to urgent indications at the first stage of complex treatment, followed by systemic chemotherapy in an adjuvant mode. After 24.5 ± 0.2 months, patients were diagnosed with metastatic liver damage, and therefore systemic chemotherapy was initiated. After changing two lines of drug therapy with a registered progression of the oncological process, liver metastases were recognized as uncontrolled by systemic chemotherapy. After that patients were included in the given study and divided into two groups. The study group included 40 patients who underwent regional chemotherapy. The control group included 36 patients who continued systemic chemotherapy with subsequent line changes. The effectiveness was evaluated according to the RECIST 1.1 and mRECIST scales, as well as the overall one-year, two- and three-year survival rates.Results. The median overall survival of patients in the control and study groups was 30.0 ± 0.8 and 41.5 ± 0.5 months, respectively, p < 0.05. The total one-year, two- and three-year survival of patients in the control and study groups was 94.4 %, 69.4 %, 33.3 % and 100 %, 82.5 %, 57.5 %, respectively, p < 0.05. The median life expectancy of deceased patients in the control and study groups was 22.5 ± 0.4 and 27.0 ± 0.4 months.Conclusions. As a result of a comparative analysis of the detection of adverse events and complications of the treatment, patients of the study group underwent treatment much easier than patients of the control group – in patients in the group of systemic chemotherapy, moderate and severe complications were detected in 44.4 % of cases, in the study group – in 2.5 % of cases. According to the results of a clinical study, regional chemotherapy is an effective method of treating patients with colon cancer metastases in the liver that are not controlled by systemic chemotherapy and is associated with a statistically significant increase in overall survival (p < 0.05). For a more detailed study of the benefits of regional chemotherapy in this category of patients, further prospective clinical studies are necessary.

22 October 2021 in Surgical Practice
Verified
Journal Article
Open access
PDF file
OSO. Yu. Stukalova
O. Yu. Stukalova
APA. A. Polikarpov
A. A. Polikarpov
RIR. V. Isсhenko
R. V. Isсhenko
In the structure of the incidence of malignant tumors for a number of years, colorectal cancer occupies one of the leading positions, with a steady tendency to growth. The five-year survival rate of patients with metastatic liver damage in colorectal cancer does not exceed 28%. A significant breakthrough in the study of the biology of colorectal cancer has led to a deep understanding of individual processes of carcinogenesis and a personalized approach to treatment tactics. Despite this, the problem of chemoresistance remains one of the most acute. The high toxicity of systemic chemotherapy limits its use in this group of patients. In this connection, minimally invasive and at the same time effective methods of local treatment of malignant liver tumors have been introduced into clinical practice. These methods include: hepatic artery chemoinfusion, chemoembolization, oil chemoembolization and radioembolization. At present, a large world experience has already been accumulated in the application of the above-described methods of treatment. However, the question of the application of methods of interventional surgery in the treatment of patients with chemoresistant metastases is still open. The presented review reflects the results of the analysis of scientific literature on the treatment of this group of patients. The main stages of development and improvement of X-ray endovascular methods of treatment are presented.

16 June 2020 in Surgical Practice
Verified
Journal Article
Open access
PDF file
RIR. V. Ischenko
R. V. Ischenko
ALA. O. Lysenko
A. O. Lysenko
The results of treatment of patients with malignant neoplasms of the biliopancreatoduodenal zone remain unsatisfactory. With this localization, pancreatoduodenal resection (PDR) remains the only radical surgical intervention. It is more advisable to start with non-surgical treatment, in the presence of arterial invasion of magistral vessels. This served as an impetus for the development of approaches to determine the presence of tumor invasion in the superior mesenteric artery at the early stage of the operation. The surgical goal of PDR remains to minimize contact with the tumor prior to mobilization and ligation of the supply vessels, as well as to increase the edge of the resection around the superior mesenteric artery. To achieve this goal, a number of researchers have proposed various approaches to the superior mesenteric artery during pancreatoduodenal resection, combined “artery-first approach”.An analysis of the existing artery-first techniques for pancreatoduodenal resections, as well as their effect on the treatment results of patients with periampullary malignant neoplasms, is carried out. When conducting literary searches, the databases Pubmed, Сochrane, EMBASE were used using the MESH keywords “Pancreaticoduodenectomy” in combination with the phrase “artery first”. During this search, 157 articles were found. After further analysis, 53 scientific papers were included in the literature review.Modern studies show a decrease in intraoperative blood loss, a decrease in the frequency of postoperative pancreatic fistulas and gastrostasis, as well as an increase in the frequency of R0 resection when this approach is followed. An unambiguous conclusion about the effectiveness of the artery first accesses when performing pancreatoduodenal resection requires further well-planned randomized clinical trials with a large number of patients.

30 August 2026 in Siberian Scientific Medical Journal
Verified
Journal Article
Open access
PDF file
Maksim SolopovMaksim Solopov
Maksim Solopov
APAndrey Popandopulo
Andrey Popandopulo
VTViktor Vasilevich Turchin
Viktor Vasilevich Turchin
AEA. A. Ermak
A. A. Ermak
SRS. A. Rudskoy
S. A. Rudskoy
РИР. В. Ищенко
Р. В. Ищенко
Accurate measurement of wound geometric parameters is essential for assessing injury severity and monitoring healing progress. Traditional manual methods have significant limitations: high error rates, subjectivity, and risk of infection. Modern digital techniques lack these drawbacks but are often expensive and complex. This study presents an alternative solution: an automated scanning platform assembled from affordable components.    Aim of the study  was to develop and validate a robotic XY-scanning platform for automated 3D analysis of ex vivo models of superficial skin wounds and to evaluate its accuracy compared to standard manual measurement methods.    Material and methods.  The hardware of the platform was developed using an Arduino Uno microcontroller, 28BYJ-48 stepper motors, and a Sharp 2Y0A21 infrared distance sensor. The software controls the scanning process and calculates wound parameters: volume (using Simpson’s method), area (using the Gaussian formula), and maximum depth. For validation, six model wounds with varying geometries were created on porcine skin samples. Their parameters were independently measured by the automated system and manual methods: volume by filling with saline solution, depth with a caliper, and area by planimetry in ImageJ software.    Results.  Statistical analysis demonstrated high agreement between automated and manual measurements. The highest accuracy was achieved in volume assessment: the mean difference between methods (0.37 cm 3 , p = 0.156), Spearman’s (ρ = 1.00) and Lin’s concordance correlation coefficient (> 0.98) indicated nearly perfect concordance. Depth measurements also showed high reliability, despite a minor systematic underestimation by the automated system averaging 0.99 mm (p = 0.094). A strong monotonic relationship was confirmed (ρ = 0.94). For wound area, a statistically significant systematic bias was identified: the platform consistently overestimated values by an average of 1.98 cm 2 (p = 0.031), likely due to hardware limitations and insufficient system resolution.    Conclusions.  The developed platform proved effective for automated, non-contact measurement of wound volume and depth, combining component affordability and automation. The main limitation is a systematic error in area measurement. Future work involves hardware modernization (installing a high-precision laser sensor) and further validation on an expanded sample of various wound types for implementation in clinical and research practice.